Shree Cement Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 6:53 pm

Quick Insight

Shree Cement Ltd's current market capitalization stands at ₹1,08,639 Cr., with a relatively high P/E ratio of 72.6. Despite a modest ROE of 5.69% and ROCE of 7.17%, the company maintains a healthy operating profit margin of 25%. Its net profit is reported at ₹1,196 Cr., supported by robust reserves of ₹21,175 Cr. However, with borrowings of ₹1,032 Cr. and a relatively high P/BV ratio of 5.11x, investors should keep a close eye on the company's financial leverage. The comfortable Interest Coverage Ratio (ICR) of 22.07x indicates a strong ability to meet interest obligations. Overall, while Shree Cement Ltd shows solid financial standing, monitoring its debt levels and profitability ratios is crucial for informed investment decisions.

Competitors of Shree Cement Ltd

All Competitor Stocks of Shree Cement Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:45 am

Below is a detailed analysis of the quarterly data for Shree Cement Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4,948.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,240.00 Cr. (Mar 2025) to 4,948.00 Cr., marking a decrease of 292.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,719.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,859.00 Cr. (Mar 2025) to 3,719.00 Cr., marking a decrease of 140.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,229.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,381.00 Cr. (Mar 2025) to 1,229.00 Cr., marking a decrease of 152.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 26.00% (Mar 2025) to 25.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 150.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 51.00 Cr..
• For Interest, as of Jun 2025, the value is 45.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.00 Cr. (Mar 2025) to 45.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 552.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 747.00 Cr. (Mar 2025) to 552.00 Cr., marking a decrease of 195.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 833.00 Cr.. The value appears strong and on an upward trend. It has increased from 743.00 Cr. (Mar 2025) to 833.00 Cr., marking an increase of 90.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 619.00 Cr.. The value appears strong and on an upward trend. It has increased from 556.00 Cr. (Mar 2025) to 619.00 Cr., marking an increase of 63.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 171.42. The value appears strong and on an upward trend. It has increased from 154.09 (Mar 2025) to 171.42, marking an increase of 17.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:05 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:22 am

Below is a detailed analysis of the balance sheet data for Shree Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 36.00 Cr..
• For Reserves, as of Mar 2025, the value is 21,175.00 Cr.. The value appears strong and on an upward trend. It has increased from 20,348.00 Cr. (Mar 2024) to 21,175.00 Cr., marking an increase of 827.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,032.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,752.00 Cr. (Mar 2024) to 1,032.00 Cr., marking a decrease of 720.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 5,512.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,282.00 Cr. (Mar 2024) to 5,512.00 Cr., marking an increase of 230.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 27,756.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27,419.00 Cr. (Mar 2024) to 27,756.00 Cr., marking an increase of 337.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,898.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,099.00 Cr. (Mar 2024) to 6,898.00 Cr., marking a decrease of 201.00 Cr..
• For CWIP, as of Mar 2025, the value is 3,112.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,833.00 Cr. (Mar 2024) to 3,112.00 Cr., marking an increase of 1,279.00 Cr..
• For Investments, as of Mar 2025, the value is 11,596.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,675.00 Cr. (Mar 2024) to 11,596.00 Cr., marking an increase of 921.00 Cr..
• For Other Assets, as of Mar 2025, the value is 6,150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,812.00 Cr. (Mar 2024) to 6,150.00 Cr., marking a decrease of 1,662.00 Cr..
• For Total Assets, as of Mar 2025, the value is 27,756.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,419.00 Cr. (Mar 2024) to 27,756.00 Cr., marking an increase of 337.00 Cr..

Notably, the Reserves (21,175.00 Cr.) exceed the Borrowings (1,032.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Shree Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 311.18. This value is within the healthy range. It has decreased from 663.98 (Mar 24) to 311.18, marking a decrease of 352.80.
• For Diluted EPS (Rs.), as of Mar 25, the value is 311.18. This value is within the healthy range. It has decreased from 663.98 (Mar 24) to 311.18, marking a decrease of 352.80.
• For Cash EPS (Rs.), as of Mar 25, the value is 1,144.84. This value is within the healthy range. It has decreased from 1,189.99 (Mar 24) to 1,144.84, marking a decrease of 45.15.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 5,969.44. It has increased from 5,749.46 (Mar 24) to 5,969.44, marking an increase of 219.98.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 5,969.44. It has increased from 5,749.46 (Mar 24) to 5,969.44, marking an increase of 219.98.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5,344.47. It has decreased from 5,687.63 (Mar 24) to 5,344.47, marking a decrease of 343.16.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1,253.67. This value is within the healthy range. It has decreased from 1,417.64 (Mar 24) to 1,253.67, marking a decrease of 163.97.
• For PBIT / Share (Rs.), as of Mar 25, the value is 420.31. This value is within the healthy range. It has decreased from 891.78 (Mar 24) to 420.31, marking a decrease of 471.47.
• For PBT / Share (Rs.), as of Mar 25, the value is 363.50. This value is within the healthy range. It has decreased from 820.18 (Mar 24) to 363.50, marking a decrease of 456.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 311.47. This value is within the healthy range. It has decreased from 664.12 (Mar 24) to 311.47, marking a decrease of 352.65.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 311.19. This value is within the healthy range. It has decreased from 664.00 (Mar 24) to 311.19, marking a decrease of 352.81.
• For PBDIT Margin (%), as of Mar 25, the value is 23.45. This value is within the healthy range. It has decreased from 24.92 (Mar 24) to 23.45, marking a decrease of 1.47.
• For PBIT Margin (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has decreased from 15.67 (Mar 24) to 7.86, marking a decrease of 7.81.
• For PBT Margin (%), as of Mar 25, the value is 6.80. This value is below the healthy minimum of 10. It has decreased from 14.42 (Mar 24) to 6.80, marking a decrease of 7.62.
• For Net Profit Margin (%), as of Mar 25, the value is 5.82. This value is within the healthy range. It has decreased from 11.67 (Mar 24) to 5.82, marking a decrease of 5.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.82. This value is below the healthy minimum of 8. It has decreased from 11.67 (Mar 24) to 5.82, marking a decrease of 5.85.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.21. This value is below the healthy minimum of 15. It has decreased from 11.57 (Mar 24) to 5.21, marking a decrease of 6.36.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 14.74 (Mar 24) to 6.67, marking a decrease of 8.07.
• For Return On Assets (%), as of Mar 25, the value is 3.94. This value is below the healthy minimum of 5. It has decreased from 8.57 (Mar 24) to 3.94, marking a decrease of 4.63.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.75 (Mar 24) to 0.68, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 2.10, marking an increase of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has increased from 1.41 (Mar 24) to 1.68, marking an increase of 0.27.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 4. It has decreased from 2.53 (Mar 24) to 0.64, marking a decrease of 1.89.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.81 (Mar 24) to 0.00, marking a decrease of 15.81.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.82 (Mar 24) to 0.00, marking a decrease of 8.82.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.19 (Mar 24) to 0.00, marking a decrease of 84.19.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.18 (Mar 24) to 0.00, marking a decrease of 91.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 22.07. This value is within the healthy range. It has increased from 19.80 (Mar 24) to 22.07, marking an increase of 2.27.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.48. This value is within the healthy range. It has decreased from 10.28 (Mar 24) to 6.48, marking a decrease of 3.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 110,615.15. It has increased from 93,833.36 (Mar 24) to 110,615.15, marking an increase of 16,781.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.74. This value exceeds the healthy maximum of 3. It has increased from 4.57 (Mar 24) to 5.74, marking an increase of 1.17.
• For EV / EBITDA (X), as of Mar 25, the value is 24.45. This value exceeds the healthy maximum of 15. It has increased from 18.35 (Mar 24) to 24.45, marking an increase of 6.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.71. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 24) to 5.71, marking an increase of 1.19.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.18 (Mar 24) to 0.00, marking a decrease of 84.18.
• For Price / BV (X), as of Mar 25, the value is 5.11. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 5.11, marking an increase of 0.63.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.71. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 24) to 5.71, marking an increase of 1.19.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness